Report

reporttype2Version of Safety Report ID3receivedateformat102transmissiondateformat102fulfillexpeditecriteria1Safety Report ID10904805serious1Date Last Updated28/03/2017receiptdateformat102companynumbUS-RANBAXY-2015US-93984occurcountryUSseriousnessother1duplicate1Date Received11/03/2015transmissiondate28/04/2017primarysourcecountryUS

Primary Source

reportercountryUSqualification5

Patient

Onset Age23Unit of Onset AgeyearsSexFemale

Contents

Reaction
- 1)
- 2)
- 3)
- 4)
Drug
summary

Reaction

1)

reactionmeddraversionpt19.1ReactionVaginal haemorrhageOutcomeNot recovered/not resolved

2)

reactionmeddraversionpt19.1ReactionAbortion inducedOutcomeUnknown

3)

reactionmeddraversionpt19.1ReactionExposure during pregnancyOutcomeRecovered/resolved

4)

reactionmeddraversionpt19.1ReactionInappropriate schedule of drug administrationOutcomeRecovered/resolved

Drug

1)

drugcharacterization1medicinalproductABSORICAdrugauthorizationnumb021951drugstructuredosagenumb30drugstructuredosageunit003drugdosagetext30 MG, QDdrugdosageformCAPSULEdrugadministrationroute065drugindicationPRODUCT USED FOR UNKNOWN INDICATIONdrugstartdateformat102drugstartdate17/12/2014drugenddateformat102drugenddate24/02/2015actiondrug1drugadditional1

activesubstance

activesubstancenameISOTRETINOIN

openFDA Info on Medication

Application NumberNDA021951Brand NameABSORICAGeneric NameISOTRETINOINManufacturersSun Pharmaceutical Industries, Inc.product_ndc 10631-115, 10631-116, 10631-117, 10631-118, 10631-133, 10631-134, 10631-002, 106 ... Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsISOTRETINOINRXCUI 197843, 197844, 197845, 403930, 1299203, 1300006, 1300014, 1300016, 1547561, 154 ... spl_ida8d4793a-5043-40e1-b623-35812733499fspl_set_id3ef0cff8-19c1-4441-b780-fca6c7ee1615Package NDC 10631-115-69, 10631-115-31, 10631-116-69, 10631-116-31, 10631-117-69, 10631-117- ... NUIN0000175607, M0018962Established Pharmacologic ClassRetinoid [EPC]Chemical StructureRetinoids [CS]UNIIEH28UP18IF

summary

narrativeincludeclinicalCASE EVENT DATE: 20141217

Report Duplicate

duplicatesourceRANBAXYduplicatenumbUS-RANBAXY-2015US-93984

Receiver

receivertype6receiverorganizationFDA

Sender

sendertype2senderorganizationFDA-Public Use

Adverse Event Report